Ann: Starpharma and Medicxi Partnership Petalion Therapeutics, page-94

Once again the nathsayers come out to play

Well I could say the following

Merck could put multiple drugs in trials using our platform
Genentech could put multiple drugs in trials using our platform
Chase Sun could put multiple drugs in trials using our platform

Dep Cabazitaxel could be licensed out to big pharma
Dep Docetaxel could be licensed out to big pharma
Dep Irinotecan could be licensed out to big pharma

SPL7013 marketed products could start generating good revenue

Preclinical drugs ready to go into trials could be licensed out to big pharma

We are now a mature company with proof of concept throughout all our in house drugs

There is no way this company is going anywhere except up in my opinion

Esmer is a non holder
AHS is a non holder
Teddyward is a non holder
WBA is a non holder

And guess what..........all spinning the same negative stories